ci8b00045_si_001.pdf (667.33 kB)
Download fileBinding of Cytotoxic Aβ25–35 Peptide to the Dimyristoylphosphatidylcholine Lipid Bilayer
journal contribution
posted on 2018-05-04, 00:00 authored by Amy K. Smith, Dmitri K. KlimovAβ25–35 is a short,
cytotoxic, and naturally occurring
fragment of the Alzheimer’s Aβ peptide. To map the molecular
mechanism of Aβ25–35 binding to the zwitterionic dimyristoylphosphatidylcholine
(DMPC) bilayer, we have performed replica exchange with solute tempering
molecular dynamics simulations using all-atom explicit membrane and
water models. Consequences of sequence truncation on the binding mechanism
have been measured by utilizing as a control our previous simulations
probing binding of the longer peptide Aβ10–40 to the
same bilayer. The most intriguing feature of Aβ25–35
binding to the DMPC bilayer is a coexistence of two bound states with
strikingly different characteristics: a dominant surface-bound state
and a less stable inserted state. In the surface-bound state, the
peptide samples extended conformations, in which its unbound C-terminal
is pointed away from the bilayer. In contrast, in the inserted state,
the C-terminal resides deep in the bilayer hydrophobic core. In both
states, the N-terminal remains anchored to the bilayer. Free energy
landscape analysis reveals that the two states are separated by a
moderate barrier, suggesting that Aβ25–35 monomer may
frequently interconvert between them. The net effect of Aβ25–35
binding is a minor impact on the bilayer structure, which contrasts
with the considerable bilayer perturbations induced by a longer Aβ10–40
peptide penetrating deep into the bilayer core. Therefore, we conclude
that the binding mechanisms of Aβ25–35 and Aβ10–40
peptides are different. Potential implications of our results for
Aβ25–35 cytotoxicity are discussed. A comparison of experimental
data with our findings reveals a good agreement.